Absolutely.
Where is the explanation of how this company will fund itself over the next FY?
Where is the update on ADAPT sales to date? And strategies for moving forward?
Where is the explanation of why ADAPT sales have dropped (note the graph where Q1FY19 is omitted to avoid demonstrating an apparent down-trend)?
Where is the guidance on TAVR and partnership?
For what it's worth, where are the explanations of the failed CRs, the rampant salaries, the slow Euro sales, the stagnant progress on Australian regulatory approval?
Anything else?
Ann: 2019 AGM Presentation, page-5
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |